| Literature DB >> 26904599 |
Adriana R Weisstaub1, Victoria Abdala1, Macarena Gonzales Chaves2, Patricia Mandalunis3, Ángela Zuleta1, Susana Zeni2.
Abstract
Purpose. To evaluate the effect of polydextrose (PDX) on Ca bioavailability and prevention of loss of bone mass. Methods. Twenty-four two-month-old ovariectomized rats were fed three isocaloric diets only varied in fiber source and content up to 60 days (FOS group, a commercial mixture of short- and long-chain fructooligosaccharide, OVX group fed AIN 93 diet, and PDX group). A SHAM group was included as control. Apparent Ca absorption percentage (%ABS), changes in total skeleton bone mineral content (tsBMC) and bone mineral density (BMD) and femur BMD, % Bone Volume, Ca and organic femur content, caecal weight, and pH were evaluated. Results. %ABS and caecum weight of PDX and FOS were higher, and caecum pH was lower compared to OVX and SHAM. PDX reached a higher pH and lower caecum weight than FOS possibly because PDX is not completely fermented in the colon. Changes in tsBMC and femur BMD in FOS and PDX were significant lower than SHAM but significantly higher than OVX. % Bone Volume and femur % of Ca in PDX were significantly higher than OVX and FOS but lower than SHAM. Conclusions. PDX increased Ca absorption and prevented bone loss in OVX rats.Entities:
Year: 2013 PMID: 26904599 PMCID: PMC4745538 DOI: 10.1155/2013/450794
Source DB: PubMed Journal: Int J Food Sci ISSN: 2314-5765
Composition of the experimental diets.
| Ingredient (g/100 g diet) | AIN 93 M diet | FOS diet | PDX diet |
|---|---|---|---|
| Protein∗ | 12.0 | 12.0 | 12.0 |
| Lipids∗∗ | 4.0 | 4.0 | 4.0 |
| Mineral mix∗∗∗ | 3.5 | 3.5 | 3.5 |
| Vitamin mix∗∗∗∗ | 1.0 | 1.0 | 1.0 |
| L-Cystine | 0.18 | 0.18 | 0.18 |
| Choline | 0.15 | 0.15 | 0.15 |
| Cellulose | 5.0 | ||
| Synergy# | 10.0 | ||
| Polydextrose## | 5.0 | ||
| Dextrin | To complete 100 g | To complete 100 g | To complete 100 g |
*Potassum Caseinate, Nestlé Argentina S.A, containing 85.1% of protein and 0.095 g% Ca.
**Commercial soy oil.
***Composition according AIN 93 M-MX.
****Composition according AIN 93-VX.
#Orafti BENEO, Tienen, Belgium.
##LitesseR, Danisco.
Dextrin was added as carbohydrate source to achieve 100 g of diet.
Food consumption throughout the study, daily intake, daily Ca intake (Ca I) and body weight (BW) gain.
| Intake (g/60 days) | Daily intake (g/day) | Ca I (mg/day) | BW gain (g/60 days) | |
|---|---|---|---|---|
| SHAM |
|
|
|
|
| OVX | 1073.8 ± 23.4* | 16.6 ± 0.3* | 83.1 ± 1.3* | 143.0 ± 31.2* |
| FOS | 987.0 ± 96.3* | 15.7 ± 1.4* | 78.3 ± 6.9* | 129.4 ± 27.3* |
| PDX | 1022.9 ± 109.4* | 16.4 ± 1.7* | 81.9 ± 8.8* | 137.1 ± 33.4* |
Data are expressed as mean ± SD.* P < 0.05 versus SHAM. Differences among groups were analyzed by Bonferroni test after ANOVA.
Figure 1Body weight (g) throughout the study. ∗P < 0.01 versus the other three studied groups. Differences were analyzed by Bonferroni test after ANOVA.
Daily fecal Ca excretion, percentage of apparent Ca absorption (% ABS) during the last three days of the experiment, and caecum weight and caecum pH at the end of the study.
| Fecal Ca (mg/day) | % ABS | Caecum weight (g) | Caecum pH | |
|---|---|---|---|---|
| SHAM |
|
|
|
|
| OVX | 45.6 ± 14.0* | 43.2 ± 5.5* | 2.40 ± 0.45 | 7.06 ± 0.19 |
| FOS | 28.0 ± 8.7∗,∗∗ | 61.6 ± 4.9∗,∗∗ | 6.05 ± 0.59∗,∗∗ | 5.77 ± 0.21∗,∗∗ |
| PDX | 28.1 ± 10.3∗,∗∗ | 58.0 ± 4.1∗,∗∗ | 4.13 ± 0.84∗,∗∗,# | 6.61 ± 0.18∗,∗∗,# |
% Abs was determined during the last three days of the experience. Data are expressed as mean ± SD. * P < 0.01 versus SHAM; ** P < 0.01 versus OVX and # P < 0.05 versus FOS. Differences among groups were analyzed by Bonferroni test after ANOVA.
Total skeleton bone mineral content (tsBMC) (expressed as mg and as mg/g BW); total skeleton bone mineral density (tsBMD) and femur BMD (fBMD) at the beginning (t = 0) and at the end of the study (t = 60) and their respective changes between t = 60 and t = 0.
| SHAM | OVX | FOS | PDX | |
|---|---|---|---|---|
| tsBMC |
| 3125 ± 630 | 2643 ± 312 | 2759 ± 265 |
| tsBMC |
| 5410 ± 416* | 5517 ± 659* | 5947 ± 592* |
| tsBMC |
| 2285 ± 214* | 3096 ± 611∗,∗∗ | 3189 ± 472∗,∗∗ |
| tBMC |
| 14.2 ± 2.6 | 13.9 ± 1.6 | 14.2 ± 1.5 |
| tBMC t = 60 (mg/g) |
| 16.0 ± 2.6* | 18.2 ± 3.1∗,# | 18.1 ± 2.6∗,# |
| tsBMC t = 60–tBMC |
| 1.33 ± 0.04* | 5.23 ± 3.55∗,∗∗ | 4.48 ± 2.41∗,∗∗ |
| tsBMD |
| 251.0 ± 5.5 | 247.7 ± 2.6 | 247.6 ± 8.0 |
| tsBMD |
| 278.5 ± 2.7 | 274.0 ± 7.5 | 278.1 ± 5.0 |
| tBMD |
| 27.5 ± 2.7* | 29.4 ± 1.9∗,# | 30.7 ± 8.8∗,# |
| fBMD |
| 232.0 ± 35.4 | 231.5 ± 17.0 | 227.7 ± 9.6 |
|
| ||||
| fBMD |
| 253.5 ± 13.4* | 278.7 ± 19.7* | 272.0 ± 9.3* |
|
| ||||
| fBMD |
| 21.5 ± 17.0* | 47.2 ± 11.1∗,∗∗ | 44.3 ± 14.6∗,∗∗ |
Data are expressed as mean ± SD. * P < 0.05 versus SHAM group; # P < 0.05, ** P < 0.01 versus OVX group. Differences were analyzed by Bonferroni test after ANOVA.
Ashes and organic femur content; ashes/organic ratio, Ca and P femur content and femur Ca/P ratio.
| SHAM | OVX | FOS | PDX | |
|---|---|---|---|---|
| Ashes content (mg/100 g BW) |
| 44.1 ± 2.5* | 51.2 ± 11.5∗,# | 54.8 ± 1.9∗,# |
| Organic content (mg/100 g BW) |
| 55.9 ± 2.4* | 57.2 ± 1.5* | 55.2 ± 1.9* |
| Ashes/Organic ratio (mg/mg) |
| 0.79 ± 0.08* | 0.89 ± 0.04# | 0.93 ± 0.16# |
| Femoral Ca content (mg/100 g BW) |
| 15.4 ± 4.1* | 18.7 ± 2.2∗,# | 20.4 ± 1.2∗,# |
| Femoral P content (mg/100 g BW) |
| 7.6 ± 1.6* | 9.5 ± 1.1∗,# | 10.2 ± 1.2∗,# |
| Femoral Ca/P ratio (mg/mg) |
| 2.00 ± 0.12 | 2.07 ± 0.20 | 2.11 ± 0.25 |
Femur parameters were determined at the end of the experience. Data are expressed as mean ± SD. * P < 0.05 versus SHAM group; * P < 0.05 versus SHAM. Differences were analyzed by Bonferroni test after ANOVA.
Figure 2Femoral bone volume percentage (BV%) at the end of the study. ∗P < 0.01 versus SHAM; # P < 0.05 versus OVX. Differences were analyzed by Bonferroni test after ANOVA.